Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments-Reference-Cited by-同舟云学术

Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments

Published:2009-08 Issue:5 Volume:14 Page:455-461
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:

Author:

DAVENPORT ANDREW

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1797.2009.01135.x/fullpdf

Reference21 articles.

1. Anticoagulation options for paediatric haemodialysis;Davenport;Hemodial. Int.,2003

2. Anticoagulation for continuous renal replacement therapy;Davenport;Contrib. Nephrol.,2004

3. Intradialytic complications during haemodialysis;Davenport;Hemodial. Int.,2006

4. Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane) and danaparoid (Orgaran) in stable chronic haemodialysis patients;Polkinghorne;Am. J. Kidney Dis.,2002

5. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic haemodialysis;Klingel;Kidney Blood Press. Res.,2004

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemodialysis;Renal Nursing;2024-06-28

2. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice;Seminars in Thrombosis and Hemostasis;2024-05-29

3. Sulfation of furcellaran and its effect on hemocompatibility in vitro;International Journal of Biological Macromolecules;2024-02

4. Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States;Renal Failure;2023-12-11

5. How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives;Seminars in Nephrology;2023-11